PFS is measured from the start of treatment until the disease _progresses_ or the patient dies from any cause, whichever happens first. Progression is typically determined through imaging studies like _CT scans_ or _MRI_s, along with clinical evaluations. The criteria for progression can vary but often include an increase in tumor size or the appearance of new lesions.
